Silicon Laboratories (NASDAQ:SLAB) has been assigned a consensus recommendation of “Buy” from the fourteen ratings firms that are presently covering the company, MarketBeat reports. Seven equities research analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average 12 month target price among brokerages that have updated their coverage on the stock in the last year is $105.10.

Several equities analysts have recently commented on the stock. BidaskClub upgraded shares of Silicon Laboratories from a “sell” rating to a “hold” rating in a research report on Tuesday, November 20th. MKM Partners lowered their target price on Silicon Laboratories to $85.00 and set a “neutral” rating on the stock in a research report on Friday, October 26th. Needham & Company LLC lowered their target price on Silicon Laboratories from $115.00 to $110.00 and set a “buy” rating on the stock in a research report on Friday, October 26th. Loop Capital lowered their target price on Silicon Laboratories from $110.00 to $90.00 and set a “hold” rating on the stock in a research report on Friday, October 26th. Finally, B. Riley lowered their target price on Silicon Laboratories from $105.00 to $100.00 and set a “buy” rating on the stock in a research report on Thursday, October 25th.

Shares of Silicon Laboratories stock traded down $2.44 during trading on Friday, hitting $82.26. 334,500 shares of the stock were exchanged, compared to its average volume of 266,065. The firm has a market capitalization of $3.72 billion, a P/E ratio of 35.00, a P/E/G ratio of 2.07 and a beta of 1.65. The company has a debt-to-equity ratio of 0.34, a quick ratio of 4.91 and a current ratio of 5.44. Silicon Laboratories has a 12 month low of $75.89 and a 12 month high of $110.70.

Silicon Laboratories (NASDAQ:SLAB) last released its quarterly earnings results on Wednesday, October 24th. The semiconductor company reported $1.01 EPS for the quarter, topping the consensus estimate of $0.98 by $0.03. The business had revenue of $230.20 million during the quarter, compared to analyst estimates of $227.36 million. Silicon Laboratories had a net margin of 7.45% and a return on equity of 12.48%. The company’s quarterly revenue was up 15.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.90 earnings per share. As a group, sell-side analysts forecast that Silicon Laboratories will post 2.77 earnings per share for the current year.

In other news, Director William G. Bock sold 1,000 shares of the company’s stock in a transaction dated Thursday, November 15th. The shares were sold at an average price of $82.75, for a total value of $82,750.00. Following the sale, the director now directly owns 39,751 shares of the company’s stock, valued at approximately $3,289,395.25. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, SVP Alessandro Piovaccari sold 1,405 shares of the company’s stock in a transaction dated Friday, September 14th. The shares were sold at an average price of $92.90, for a total transaction of $130,524.50. Following the completion of the sale, the senior vice president now directly owns 29,669 shares in the company, valued at $2,756,250.10. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 4,931 shares of company stock worth $418,026. 1.96% of the stock is owned by insiders.

Hedge funds have recently modified their holdings of the company. Frontier Capital Management Co. LLC raised its holdings in Silicon Laboratories by 310.3% in the 3rd quarter. Frontier Capital Management Co. LLC now owns 551,776 shares of the semiconductor company’s stock valued at $50,653,000 after acquiring an additional 417,299 shares during the period. Eagle Asset Management Inc. raised its holdings in Silicon Laboratories by 54.0% in the 2nd quarter. Eagle Asset Management Inc. now owns 511,076 shares of the semiconductor company’s stock valued at $50,903,000 after acquiring an additional 179,120 shares during the period. Advisors Asset Management Inc. raised its holdings in Silicon Laboratories by 7,462.3% in the 2nd quarter. Advisors Asset Management Inc. now owns 159,187 shares of the semiconductor company’s stock valued at $224,000 after acquiring an additional 157,082 shares during the period. Vanguard Group Inc. raised its holdings in Silicon Laboratories by 2.3% in the 3rd quarter. Vanguard Group Inc. now owns 3,995,961 shares of the semiconductor company’s stock valued at $366,828,000 after acquiring an additional 90,944 shares during the period. Finally, FMR LLC raised its holdings in Silicon Laboratories by 1.2% in the 2nd quarter. FMR LLC now owns 6,484,660 shares of the semiconductor company’s stock valued at $645,872,000 after acquiring an additional 75,633 shares during the period. 92.37% of the stock is currently owned by institutional investors.

About Silicon Laboratories

Silicon Laboratories Inc, a fabless semiconductor company, designs, develops, and markets mixed-signal integrated circuits (ICs) in the United States, China, and internationally. The company offers Internet of things products, such as 8-bit mixed-signal, 32-bit wireless, and ultra-low-power 32-bit microcontrollers; wireless connectivity devices, including multiprotocol wireless Gecko system-on-chip devices; real-time operating systems; sensor products comprising optical, relative humidity/temperature, and hall effect magnetic sensors.

Recommended Story: How to use beta for portfolio diversification

Analyst Recommendations for Silicon Laboratories (NASDAQ:SLAB)

Receive News & Ratings for Silicon Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silicon Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.